BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)

€57.50 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.

Amount in mg:

5 mg

  • EP11088_1
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual... more
Product information "BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)"

This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed BCR-ABL 210 kD fusion protein-derived peptide of ATGFKQSSK sequence covering 259-269 and A*03:01, A*11:01 molecule.

Available downloads:

 
Sequence:ATGFKQSSK
Gene:BCR
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Human Bcr-abl 210 kD fusion protein
Species:Human
Allele:HLA-A*03:01 HLA-A*11:01
Application :Flow Cytometry
Indication :Cancer
####
    p53 (Y220C)
    From €57.50 *
    HEL 11-25
    From €115.00 *
    Proinsulin 90-104
    From €115.00 *
    HPV E6 31-38
    From €57.50 *
    LCMV NP 201-215
    From €115.00 *
    HDV 46-54
    From €57.50 *
    SUMO2 57-66
    From €57.50 *
    SUMO1 57-67
    From €57.50 *
    Env 345-359
    From €149.50 *
    MOG 37-50
    From €115.00 *
    Influenza NP 50-57
    From €57.50 *
    Viewed
    BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)